The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Prof. John Smyth

Prof. John Smyth is the Deputy Chairman of CDDF Board of Directors

John Smyth is Emeritus Professor of Medical Oncology in the University of Edinburgh, where his major research interest has been the development and evaluation of new anti-cancer drugs.

He has published over 300 papers and is past Editor-in-Chief of the European Journal of Cancer.

He served for several years on the UK Committee on Safety of Medicines; currently Chair’s the Expert Advisory Group for Oncology & Haematology for the Commission on Human Medicines and has served on the Scientific Advisory Group for Oncology to the EMEA.

He is a fellow of the Royal College of Physicians of Edinburgh and London, and fellow of the Royal Society of Edinburgh.

He is a past-president of the European Society of Medical Oncology and was from 2005 – 2007 President of the Federation of European Cancer Societies.

Contact Prof. John Smyth

Cancer Drug Development Forum
c/o BLSI
Clos Chapelle-aux-Champs 30
1200 Brussels, Belgium
Tel: +32 2 880 62 70

Legal address
c/o Deloitte Tirol
Wirtschaftsprüfungs GmbH,
Wilhelm-Greil-Str. 15,
6020 Innsbruck, Austria